Inventor · disambiguated record
Jun Chen
Also filed as: CHEN JUN · CHEN JUN-AN
17 granted patents·20 pending applications·50 citations·filing 1997–2023
91Inventor score
Files withPHARMACYCLICS LLC7HEFEI LIFEON PHARMACEUTICAL CO LTD6JANSSEN BIOTECH INC4ADAGENE INC3UAB RESEARCH FOUNDATION3
Top patents by PatentIndex Score
37 records- 0194US9415050B2Methods for the treatment of HER2 amplified cancerPHARMACYCLICS LLC·Filed 2014·Granted Aug 16, 2016·17 cites·21 claims
- 0292US11242395B2Anti-CD137 molecules and use thereofADAGENE INC·Filed 2018·Granted Feb 8, 2022·13 cites·29 claims
- 0386US11859003B2Method for treating cancer using anti-CD137 antibodyADAGENE INC·Filed 2018·Granted Jan 2, 2024·3 cites·18 claims
- 0484US10913094B2Multi-unit rotary system and method for storage, intelligent sorting and picking of express parcelsUNIV NORTHEASTERN·Filed 2016·Granted Feb 9, 2021·9 cites·10 claims
- 0583US10016434B2Methods for the treatment of HER2 amplified cancerPHARMACYCLICS LLC·Filed 2017·Granted Jul 10, 2018·2 cites·14 claims
- 0682US9724349B2Methods for the treatment of HER2 amplified cancerPHARMACYCLICS LLC·Filed 2016·Granted Aug 8, 2017·2 cites·11 claims
- 0781US12129310B2Materials and methods for enhanced linker targetingJANSSEN BIOTECH INC·Filed 2023·Granted Oct 29, 2024·0 cites·16 claims
- 0873US11639396B2Antibody binding to a linker peptideJANSSEN BIOTECH INC·Filed 2022·Granted May 2, 2023·0 cites·15 claims
- 0971US12378319B2Anti-CD137 molecules and use thereofADAGENE INC·Filed 2021·Granted Aug 5, 2025·0 cites·13 claims
- 1070US2021145835A1Methods for the treatment of her2 amplified cancerPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 1169US2024154113A1Ampere-hour-scale sodium-ion pouch cellUNIV NANKAI·Filed 2023·Application pending·0 cites
- 1267US11970529B2Protein binding to fibronectin B domainHEFEI LIFEON PHARMACEUTICAL CO LTD·Filed 2021·Granted Apr 30, 2024·0 cites·12 claims
- 1363US2019167687A1Methods for the treatment of her2 amplified cancerPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 1463US2025115874A1Compositions And Methods For Making And Using Atherosclerotic Nanomatrix Vascular SheetsUAB RESEARCH FOUNDATION·Filed 2023·Application pending·0 cites
- 1561US2024218017A1Peptide amphiphiles with modified degrading sequences and methods of use thereofUAB RESEARCH FOUNDATION·Filed 2023·Application pending·0 cites
- 1661US2025368756A1Enhanced protein compositionsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1761US2024199698A1Peptide amphiphile compositions and methods of use thereofUAB RESEARCH FOUNDATION·Filed 2023·Application pending·0 cites
- 1860US11192943B2Protein binding to fibronectin B domainHEFEI LIFEON PHARMACEUTICAL CO LTD·Filed 2018·Granted Dec 7, 2021·0 cites·12 claims
- 1960US2024197832A1Methods and materials for treating a strokeUNIV OF PITTSBURGH – OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 2058US10888544B2Methods for treating Gaucher diseaseGENZYME CORP·Filed 2018·Granted Jan 12, 2021·0 cites·9 claims
- 2158US2025019455A1Proteins comprising cd20 binding domains, and uses thereofPHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2257US9073995B2Bladder cancer tumor marker, antibody and use thereofLI CHONG·Filed 2011·Granted Jul 7, 2015·1 cites·8 claims
- 2355US10611830B2Human antibody against ED-B domain of fibronectin and uses thereofHEFEI LIFEON PHARMACEUTICAL CO LTD·Filed 2014·Granted Apr 7, 2020·0 cites·11 claims
- 2455US2023174651A1Materials and methods for hinge regions in functional exogenous receptorsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2554US2020030330A1Bruton's tyrosine kinase inhibitor combinations and uses thereofPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 2654US2025188431A1Engineered nuclease and use thereofQINGDAO KINGAGROOT CHEMICAL COMPOUND CO LTD·Filed 2023·Application pending·0 cites
- 2753US11878963B2Semi synthetic method for dihydroquercetinHEFEI LIFEON PHARMACEUTICAL CO LTD·Filed 2022·Granted Jan 23, 2024·0 cites·20 claims
- 2851US2021330633A1Methods for treating gaucher diseaseGENZYME CORP·Filed 2020·Application pending·0 cites
- 2951US2017027941A1Bruton's Tyrosine Kinase Inhibitor Combinations and Uses ThereofPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 3047US2021155691A1Methods of preventing or treating non-hematopoietic slamf7 positive and slamf7 negative cancersADAERATA LP·Filed 2019·Application pending·0 cites
- 3141US12144822B2Mir-17˜92 as therapeutic or diagnostic target of motor neuron (MN) degeneration diseasesACADEMIA SINICA·Filed 2019·Granted Nov 19, 2024·0 cites·8 claims
- 3241US2019135921A1Methods of preventing or treating slamf7 positive and slamf7 negative cancersADAERATA LP·Filed 2017·Application pending·0 cites
- 3340US5968771AGlobal ischemia induced geneUNIV PITTSBURGH·Filed 1997·Granted Oct 19, 1999·3 cites·9 claims
- 3437US2008193973A1Bacillus Subtilis Strain and its Use in Preparing Pharmaceuticals for Treating ThrombosisCHENGDU DI AO JIUHONG PHARMACE·Filed 2006·Application pending·0 cites
- 3536US2019002516A1Drug Design Method, Obtained Drug and Application ThereofHEFEI LIFEON PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 3635US2011136916A16-shogaol for using in a method for the treatment of leukemiaUNIV CHINA PHARMA·Filed 2010·Application pending·0 cites
- 3734US2018340936A1Use of ed-b protein in diagnosis of tissue hyperplasiaHEFEI LIFEON PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jun Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →